The efficacy of duloxetine for neuropathic pain a comparison of pregabali
Not Applicable
- Conditions
- neuropathic pain
- Registration Number
- JPRN-UMIN000028475
- Lead Sponsor
- Kajiki Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
can not be self-assessment of pain
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual analogue scale (VAS) is assessed before, and, 1 week, 2 weeks, 1 month, 2 months, 3 months after drug administration
- Secondary Outcome Measures
Name Time Method